The clinical application of glibenclamide: the problem of safety and efficacy | Zendy

Г К Решедько | Zendy; E.V. Khaikina | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The clinical application of glibenclamide: the problem of safety and efficacy

Author(s) -

Г К Решедько,

E.V. Khaikina

Publication year - 2012

Publication title -

problems of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.124

H-Index - 5

eISSN - 2308-1430

pISSN - 0375-9660

DOI - 10.14341/probl201258365-69

Subject(s) - glibenclamide , medicine , intensive care medicine , type 2 diabetes mellitus , diabetes mellitus , clinical practice , type 2 diabetes , clinical efficacy , surgery , physical therapy , endocrinology

Well-timed, effective, and safe therapy of type 2 diabetes mellitus (DM2) is a challenging problem for public healthcare systems all over the world. Glibenclamide is currently the most popular sulfanylurea derivative prescribed to the patients presenting with DM2. High requirements to the safety profile of modern medications including oral hypoglycemic agents imply the necessity of close attention to the potential problems associated with the long-term application of glibennclamide. The present review is focused on the topical problems of safety and efficacy of glibenclamide arising from its use in the clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research